Ultrasonic mist inhaler

Information

  • Patent Grant
  • 11911559
  • Patent Number
    11,911,559
  • Date Filed
    Sunday, December 15, 2019
    4 years ago
  • Date Issued
    Tuesday, February 27, 2024
    2 months ago
Abstract
An ultrasonic mist inhaler, including a liquid reservoir structure including a liquid chamber adapted to receive liquid to be atomized, the liquid chamber including a top surface representing a maximum level of the liquid chamber and a bottom surface representing a minimum level of the liquid chamber, a sonication chamber in fluid communication with the liquid chamber, the sonication chamber includes a piezoelectric transducer and a capillary material extending between the sonication chamber and the liquid chamber, wherein the piezoelectric transducer and the liquid chamber are arranged according to one of the following configurations: the piezoelectric transducer is disposed close to or at the bottom surface of the liquid chamber, the piezoelectric transducer is disposed close to or at the top surface of the liquid chamber as depicted in FIG. 3.
Description
CROSS-REFERENCE TO RELATED APPLICATION

This application is a U.S. national stage application under section 35 U.S.C. § 371 of International Application No. PCT/IB2019/060808, filed Dec. 15, 2019, the entire contents of which are incorporated herein in its entirety.


FIELD OF THE DISCLOSED TECHNOLOGY

The invention relates to an ultrasonic mist inhaler for atomizing a liquid by ultrasonic vibrations.


BACKGROUND

Electronic vaporizing inhalers are becoming popular among smokers who also want to avoid the tar and other harsh chemicals associated with traditional cigarettes and who wish to satisfy the craving for nicotine. Electronic vaporizing inhalers may contain liquid nicotine, which is typically a mixture of nicotine oil, a solvent, water, and sometimes flavoring. When the user draws, or inhales, on the electronic vaporizing inhaler, the liquid nicotine is drawn into a vaporizer where it is heated into a vapor. As the user draws on the electronic vaporizing inhaler, the vapor containing the nicotine is inhaled. Such electronic vaporizing inhalers may have medical purpose.


Electronic vaporizing inhalers and other vapor inhalers typically have similar designs. Most electronic vaporizing inhalers feature a liquid nicotine reservoir with an interior membrane, such as a capillary element, typically cotton, that holds the liquid nicotine so as to prevent leaking from the reservoir. Nevertheless, these cigarettes are still prone to leaking because there is no obstacle to prevent the liquid from flowing out of the membrane and into the mouthpiece. A leaking electronic vaporizing inhaler is problematic for several reasons. As a first disadvantage, the liquid can leak into the electronic components, which can cause serious damage to the device. As a second disadvantage, the liquid can leak into the electronic vaporizing inhaler mouthpiece, and the user may inhale the unvaporized liquid.


Electronic vaporizing inhalers are also known for providing inconsistent doses between draws. The aforementioned leaking is one cause of inconsistent doses because the membrane may be oversaturated or undersaturated near the vaporizer. If the membrane is oversaturated, then the user may experience a stronger than desired dose of vapor, and if the membrane is undersaturated, then the user may experience a weaker than desired dose of vapor. Additionally, small changes in the strength of the user's draw may provide stronger or weaker doses. Inconsistent dosing, along with leaking, can lead to faster consumption of the vaping liquid.


Additionally, conventional electronic vaporizing inhalers tend to rely on inducing high temperatures of a metal heating component configured to heat a liquid in the e-cigarette, thus vaporizing the liquid that can be breathed in. Problems with conventional electronic vaporizing inhalers may include the possibility of burning metal and subsequent breathing in of the metal along with the burnt liquid. In addition, some may not prefer the burnt smell caused by the heated liquid.


Electronic vaporizing inhalers are generally designed so that the liquid nicotine reservoir is arranged away from the metal heating component to prevent heating the unused liquid in the reservoir. This arrangement makes the inhaler device cumbersome and more complex to produce.


In the electronic vaporizing inhalers, the vapor chamber is generally distant from the liquid reservoir and the mouthpiece to prevent heating the liquid or the vapor before the user drawn.


Thus, a need exists in the art for an electronic vaporizing inhaler that is better able to withstand these disadvantages.


BRIEF SUMMARY

According to one aspect of the invention, an ultrasonic mist inhaler, comprises:

    • a liquid reservoir structure comprising a liquid chamber adapted to receive liquid to be atomized,
    • the liquid chamber comprising a top surface representing the maximum level of the liquid chamber and the bottom surface representing the minimum level of the liquid chamber,
    • a sonication chamber in fluid communication with the liquid chamber,
    • the sonication chamber comprising means of ultrasonic vibrations and a capillary element extending between the sonication chamber and the liquid chamber,


wherein the means of ultrasonic vibrations and the liquid chamber are arranged according to one of the following configurations:

    • the means of ultrasonic vibrations are disposed close to or at the bottom surface of the liquid chamber,
    • the means of ultrasonic vibrations are disposed close to or at the top surface of the liquid chamber.


The arrangement of the means of ultrasonic vibrations disposed close to or at the bottom surface of the liquid chamber renders the fluid passage to the means of ultrasonic vibrations by gravity faster.


The arrangement of the means of ultrasonic vibrations disposed close to or at the top surface of the liquid chamber renders the mist passage to a mouthpiece shorter.


The expression “means of ultrasonic vibrations” is similar to the expression “ultrasonic oscillation component” used in the patent application PCT/IB2019/055192.


In the ultrasonic mist inhaler, in the arrangement close to or at the top surface, the means of ultrasonic vibrations may have at least an atomization surface parallel to the top surface.


In the ultrasonic mist inhaler, in the arrangement close to or at the top surface, the means of ultrasonic vibrations may have at least an atomization surface perpendicular to the top surface.


The atomization surface perpendicular to the top surface permits smaller thickness of the inhaler.


In the configuration of the atomization surface perpendicular to the top surface, the inhaler may comprise one of the following features taken alone or in combination:

    • the liquid reservoir structure may comprise an inner container and an outer container wherein the inner container is surrounded by the outer container, the inner container forms the liquid reservoir,
    • the capillary element is wrapped around the means of ultrasonic vibrations,
    • the means of ultrasonic vibrations is supported by an elastic member,
    • the elastic member is formed from an annular plate-shaped rubber,
    • the elastic member has an inner hole wherein a groove is designed for maintaining the means of ultrasonic vibrations,
    • the inner container has an opening into which the elastic member is introduced at least partly, the elastic member having a radial groove wherein the capillary element passes and penetrates the liquid chamber,
    • the elastic member is inserted into the opening of the inner container by tight adjustment.


It is noted that the expression “mist” used in the invention means the liquid is not heated as usually in traditional inhalers known from the prior art. In fact, traditional inhalers use heating elements to heat the liquid above its boiling temperature to produce a vapor, which is different from a mist.


In fact, when sonicating liquids at high intensities, the sound waves that propagate into the liquid media result in alternating high-pressure (compression) and low-pressure (rarefaction) cycles, at different rates depending on the frequency. During the low-pressure cycle, high-intensity ultrasonic waves create small vacuum bubbles or voids in the liquid. When the bubbles attain a volume at which they can no longer absorb energy, they collapse violently during a high-pressure cycle. This phenomenon is termed cavitation. During the implosion very high pressures are reached locally. At cavitation, broken capillary waves are generated, and tiny droplets break the surface tension of the liquid and are quickly released into the air, taking mist form.


The ultrasonic mist inhaler according to the invention, wherein said liquid to be received in the liquid chamber comprises 57-70% (w/w) vegetable glycerin and 30-43% (w/w) propylene glycol, said propylene glycol including nicotine and flavorings.


An ultrasonic mist inhaler or a personal ultrasonic atomizer device, comprising:

    • a liquid reservoir structure comprising a liquid chamber or cartridge adapted to receive liquid to be atomized,
    • a sonication chamber in fluid communication with the liquid chamber or cartridge,


wherein said liquid to be received in the liquid chamber comprises 57-70% (w/w) vegetable glycerin and 30-43% (w/w) propylene glycol, said propylene glycol including nicotine and flavorings.





BRIEF DESCRIPTION OF THE DRAWINGS

Some embodiments are illustrated by way of example and not limitation in the figures of the accompanying drawings.



FIG. 1 is an exploded view of components of the ultrasonic mist inhaler according to a first arrangement of means of ultrasonic vibrations disposed close to or at a bottom surface of a liquid chamber.



FIG. 2 is an exploded view of components of the inhaler liquid reservoir structure according to the first arrangement.



FIG. 3 is a cross section view of components of the inhaler liquid reservoir structure according to FIG. 1 or 2 wherein means of ultrasonic vibrations are arranged according to a first embodiment.



FIG. 4A is an isometric view of an airflow member of the inhaler liquid reservoir structure according to FIGS. 2 and 3.



FIG. 4B is a cross section view of the airflow member shown in FIG. 4A.



FIG. 5 is a cross section view of a second arrangement of means of ultrasonic vibrations disposed close to or at a top surface of the liquid chamber.



FIG. 6 is a cross section view of a second arrangement of means of ultrasonic vibrations disposed close to or at the top surface of the liquid chamber.





DETAILED DESCRIPTION

The foregoing summary, as well as the following detailed description of certain embodiments of the present invention, will be better understood when read in conjunction with the appended drawings.


As used herein, an element recited in the singular and preceded with the word “a” or “an” should be understood as not excluding plural of said elements, unless such exclusion is explicitly stated. Furthermore, the references to “one embodiment” of the present invention are not intended to be interpreted as excluding the existence of additional embodiments that also incorporate the recited features. Moreover, unless explicitly stated to the contrary, embodiments “comprising” or “having” an element or a plurality of elements having a particular property may include additional such elements not having that property.


The present invention is directed to an ultrasonic mist inhaler. The description of the invention and accompanying figures will be directed to the electronic vaporizing inhaler embodiment; however, other embodiments are envisioned, such as an inhaler for hookah, flavored liquids, medicine, and herbal supplements. Additionally, the device can be packaged to look like an object other than a cigarette. For instance, the device could resemble another smoking instrument, such as a pipe, water pipe, or slide, or the device could resemble another non-smoking related object.


Ultrasonic mist inhalers are either disposable or reusable. The term “reusable” as used herein implies that the energy storage device is rechargeable or replaceable or that the liquid is able to be replenished either through refilling or through replacement of the liquid reservoir structure. Alternatively, in some embodiments reusable electronic device is both rechargeable and the liquid can be replenished. A disposable embodiment will be described first, followed by a description of a reusable embodiment.


Conventional electronic vaporizing inhaler tend to rely on inducing high temperatures of a metal component configured to heat a liquid in the inhaler, thus vaporizing the liquid that can be breathed in. The liquid typically contains nicotine and flavorings blended into a solution of propylene glycol (PG) and vegetable glycerin (VG), which is vaporized via a heating component at high temperatures. Problems with conventional inhaler may include the possibility of burning metal and subsequent breathing in of the metal along with the burnt liquid. In addition, some may not prefer the burnt smell or taste caused by the heated liquid.


In contrast, aspects of the present disclosure include an ultrasonic mist inhaler that atomizes the liquid through ultrasonic vibrations, which produces micro water bubbles in the liquid. When the bubbles come into contact with ambient air, water droplets of about 0.25 to 0.5 microns spray into the air, thereby generating micro-droplets that can be absorbed through breathing, similar to breathing in a mist.


No heating elements are involved, thereby leading to no burnt elements and reducing second-hand smoke effects.



FIG. 1 to FIG. 4 illustrate a first arrangement of means of ultrasonic vibrations disposed close to or at a bottom surface of a liquid chamber.



FIG. 1 depicts a disposable ultrasonic mist inhaler embodiment 100 of the invention. As can be seen in FIG. 1, the ultrasonic mist inhaler 100 has a cylindrical body with a relatively long length as compared to the diameter. In terms of shape and appearance, the ultrasonic mist inhaler 100 is designed to mimic the look of a typical cigarette. For instance, the inhaler can feature a first portion 101 that primarily simulates the tobacco rod portion of a cigarette and a second portion 102 that primarily simulates a filter. In the disposable embodiment of the invented device, the first portion and second portion are regions of a single, but-separable device. The designation of a first portion 101 and a second portion 102 is used to conveniently differentiate the components that are primarily contained in each portion.


As can be seen in FIG. 1, the ultrasonic mist inhaler comprises a mouthpiece 1, a liquid reservoir structure 2 and a casing 3. The first portion 101 comprises the casing 3 and the second portion 102 comprises the mouthpiece 1 and the reservoir structure 2.


The first portion 101 contains the power supply energy.


An electrical storage device 30 powers the ultrasonic mist inhaler 100. The electrical storage device 30 can be a battery, including but not limited to a lithium-ion, alkaline, zinc-carbon, nickel-metal hydride, or nickel-cadmium battery; a super capacitor; or a combination thereof. In the disposable embodiment, the electrical storage device 30 is not rechargeable, but, in the reusable embodiment, the electrical storage device 30 would be selected for its ability to recharge. In the disposable embodiment, the electrical storage device 30 is primarily selected to deliver a constant voltage over the life of the inhaler 100. Otherwise, the performance of the inhaler would degrade over time. Preferred electrical storage devices that are able to provide a consistent voltage output over the life of the device include lithium-ion and lithium polymer batteries.


The electrical storage device 30 has a first end 30a that generally corresponds to a positive terminal and a second end 30b that generally corresponds to a negative terminal. The negative terminal is extending to the first end 30a.


Because the electrical storage device 30 is located in the first portion 101 and the liquid reservoir structure 2 is located in the second portion 102, the joint needs to provide electrical communication between those components. In the present invention, electrical communication is established using at least an electrode or probe that is compressed together when the first portion 101 is tightened into the second portion 102.


In order for this embodiment to be reusable, the electrical storage device 30 is rechargeable. The casing 3 contains a charging port 32.


The integrated circuit 4 has a proximal end 4a and a distal end 4b. The positive terminal at the first end 30a of the electrical storage device 30 is in electrical communication with a positive lead of the flexible integrated circuit 4. The negative terminal at the second end 30b of the electrical storage device 30 is in electrical communication with a negative lead of the integrated circuit 4. The distal end 4b of the integrated circuit 4 comprise a microprocessor. The microprocessor is configured to process data from a sensor, to control a light, to direct current flow to means of ultrasonic vibrations 5 in the second portion 102, and to terminate current flow after a preprogrammed amount of time.


The sensor detects when the ultrasonic mist inhaler 100 is in use (when the user draws on the inhaler) and activates the microprocessor. The sensor can be selected to detect changes in pressure, air flow, or vibration. In a preferred embodiment, the sensor is a pressure sensor. In the digital embodiment, the sensor takes continuous readings which in turn requires the digital sensor to continuously draw current, but the amount is small and overall battery life would be negligibly affected.


Additionally, the integrated circuit 4 may comprise a H bridge, preferably formed by 4 MOSFETs to convert a direct current into an alternate current at high frequency.


Referring to FIG. 2 and FIG. 3, illustrations of a liquid reservoir structure 2 according to an embodiment are shown. The liquid reservoir structure 2 comprises a liquid chamber 21 adapted to receive liquid to be atomized and a sonication chamber 22 in fluid communication with the liquid chamber 21.


In the embodiment shown, the liquid reservoir structure 2 comprises an inhalation channel 20 providing an air passage from the sonication chamber 22 toward the surroundings.


As an example of sensor position, the sensor may be located in the sonication chamber 22.


The inhalation channel 20 has a frustoconical element 20a and an inner container 20b.


As depicted in FIGS. 4A and 4B, further the inhalation channel 20 has an airflow member 27 for providing air flow from the surroundings to the sonication chamber 22.


The airflow member 27 has an airflow bridge 27a and an airflow duct 27b made in one piece, the airflow bridge 27a having two airway openings 27a′ forming a portion of the inhalation channel 20 and the airflow duct 27b extending in the sonication chamber 22 from the airflow bridge 27a for providing the air flow from the surroundings to the sonication chamber.


The airflow bridge 27a cooperates with the frustoconical element 20a at the second diameter 20a2.


The airflow bridge 27a has two opposite peripheral openings 27a″ providing air flow to the airflow duct 27b.


The cooperation with the airflow bridge 27a and the frustoconical element 20a is arranged so that the two opposite peripheral openings 27a″ cooperate with complementary openings 20a″ in the frustoconical element 20a.


The mouthpiece 1 and the frustoconical element 20a are radially spaced and an airflow chamber 28 is arranged between them.


As depicted in FIGS. 1 and 2, the mouthpiece 1 has two opposite peripheral openings 1″.


The peripheral openings 27a″, 20a″, 1″ of the airflow bridge 27a, the frustoconical element 20a and the mouthpiece 1 directly supply maximum air flow to the sonication chamber 22.


The frustoconical element 20a includes an internal passage, aligned in the similar direction as the inhalation channel 20, having a first diameter 20a1 less than that of a second diameter 20a2, such that the internal passage reduces in diameter over the frustoconical element 20a.


The frustoconical element 20a is positioned in alignment with the means of ultrasonic vibrations 5 and a capillary element 7, wherein the first diameter 20a1 is linked to an inner duct 11 of the mouthpiece 1 and the second diameter 20a2 is linked to the inner container 20b.


The inner container 20b has an inner wall delimiting the sonication chamber 22 and the liquid chamber 21.


The liquid reservoir structure 2 has an outer container 20c delimiting the outer wall of the liquid chamber 21.


The inner container 20b and the outer container 20c are respectively the inner wall and the outer wall of the liquid chamber 21.


The liquid reservoir structure 2 is arranged between the mouthpiece 1 and the casing 3 and is detachable from the mouthpiece 1 and the casing 3.


The liquid reservoir structure 2 and the mouthpiece 1 or the casing 3 may include complimentary arrangements for engaging with one another; further such complimentary arrangements may include one of the following: a bayonet type arrangement; a threaded engaged type arrangement; a magnetic arrangement; or a friction fit arrangement; wherein the liquid reservoir structure 2 includes a portion of the arrangement and the mouthpiece 1 or the casing 3 includes the complimentary portion of the arrangement.


In the reusable embodiment, the components are substantially the same. The differences in the reusable embodiment vis-a-vis the disposable embodiment are the accommodations made to replace the liquid reservoir structure 2.


As shown in FIG. 3, the liquid chamber 21 has a top wall 23 and a bottom wall 25 closing the inner container 20b and the outer container 20c of the liquid chamber 21.


The capillary element 7 is arranged between a first section 20b1 and a second section 20b2 of the inner container 20b.


The capillary element 7 has a flat shape extending from the sonication chamber to the liquid chamber.


As depicted in FIG. 2 or 3, the capillary element 7 comprises a central portion 7a in U-shape and a peripheral portion 7b in L-shape.


The L-shape portion 7b extends into the liquid chamber 21 on the inner container 20b and along the bottom wall 25.


The U-shape portion 7a is contained into the sonication chamber 21. The U-shape portion 7a on the inner container 20b and along the bottom wall 25.


In the ultrasonic mist inhaler, the U-shape portion 7a has an inner portion 7a1 and an outer portion 7a2, the inner portion 7a1 being in surface contact with an atomization surface 50 of the means of ultrasonic vibrations 5 and the outer portion 7a2 being not in surface contact with the means of ultrasonic vibrations 5.


The bottom wall 25 of the liquid chamber 21 is a bottom plate 25 closing the liquid chamber 21 and the sonication chamber 22. The bottom plate 25 is sealed, thus preventing leakage of liquid from the sonication chamber 22 to the casing 3.


The bottom plate 25 has an upper surface 25a having a recess 25b on which is inserted an elastic member 8. The means of ultrasonic vibrations 5 are supported by the elastic member 8. The elastic member 8 is formed from an annular plate-shaped rubber having an inner hole 8′ wherein a groove is designed for maintaining the means of ultrasonic vibrations 5.


The top wall 23 of the liquid chamber 21 is a cap 23 closing the liquid chamber 23.


The top wall 23 has a top surface 23 representing the maximum level of the liquid that the liquid chamber 21 may contain and the bottom surface 25 representing the minimum level of the liquid in the liquid chamber 21.


The top wall 23 is sealed, thus preventing leakage of liquid from the liquid chamber 21 to the mouthpiece 1.


The top wall 23 and the bottom wall 25 are fixed to the liquid reservoir structure 2 by means of fixation such as screws, glue, or friction.


As depicted in FIG. 3, the elastic member 8 is in line contact with the means of ultrasonic vibrations 5 and prevents contact between the means of ultrasonic vibrations 5 and the inhaler walls, suppression of vibrations of the liquid reservoir structure are more effectively prevented. Thus, fine particles of the liquid atomized by the atomizing member can be sprayed farther.


As depicted in FIG. 3, the inner container 20b has openings 20b′ between the first section 20b1 and the second section 20b2 from which the capillary element 7 is extending from the sonication chamber 21. The capillary element 7 absorbs liquid from the liquid chamber 21 through the apertures 20b′. The capillary element 7 is a wick. The capillary element 7 transports liquid to the sonication chamber 22 via capillary action. Preferably the capillary element 7 is made of bamboo fibers; however, cotton, paper, or other fiber strands could be used for a wick material.


In one embodiment of the ultrasonic mist inhaler 100, as can be seen in FIG. 3, the means of ultrasonic vibrations 5 are disposed directly below the capillary element 7.


The means of ultrasonic vibrations 5 may be a transducer. For example, the means of ultrasonic vibrations 5 may be a piezoelectric transducer, preferably designed in a circular plate-shape. The material of the piezoelectric transducer is preferably in ceramic.


A variety of transducer materials can also be used for the means of ultrasonic vibrations 5.


The end of the airflow duct 27b1 faces the means of ultrasonic vibrations 5. The means of ultrasonic vibrations 5 are in electrical communication with electrical contactors 101a, 101b. It is noted that, the distal end 4b of the integrated circuit 4 has an inner electrode and an outer electrode. The inner electrode contacts the first electrical contact 101a which is a spring contact probe, and the outer electrode contacts the second electrical contact 101b which is a side pin. Via the integrated circuit 4, the first electrical contact 101a is in electrical communication with the positive terminal of the electrical storage device 30 by way of the microprocessor, while the second electrical contact 101b is in electrical communication with the negative terminal of the electrical storage device 30.


The electrical contacts 101a, 101b crossed the bottom plate 25. The bottom plate 25 is designed to be received inside the perimeter wall 26 of the liquid reservoir structure 2. The bottom plate 25 rests on complementary ridges, thereby creating the liquid chamber 21 and sonication chamber 22.


The inner container 20b comprises a circular inner slot 20d on which a mechanical spring is applied.


By pushing the central portion 7a1 onto the means of ultrasonic vibrations 5, the mechanical spring 9 ensures a contact surface between them.


The liquid reservoir structure 2 and the bottom plate 25 can be made using a variety of thermoplastic materials.


When the user draws on the ultrasonic mist inhaler 100, an air flow is drawn from the peripheral openings 1″ and penetrates the airflow chamber 28, passes the peripheral openings 27a″ of the airflow bridge 27a and the frustoconical element 20a and flows down into the sonication chamber 22 via the airflow duct 27b directly onto the capillary element 7. At the same time, the liquid is drawn from the reservoir chamber 21 by capillarity, through the plurality of apertures 20b′, and into the capillary element 7. The capillary element 7 brings the liquid into contact with the means of ultrasonic vibrations 5 of the inhaler 100. The user's draw also causes the pressure sensor to activate the integrated circuit 4, which directs current to the means of ultrasonic vibrations 5. Thus, when the user draws on the mouthpiece 1 of the inhaler 100, two actions happen at the same time. Firstly, the sensor activates the integrated circuit 4, which triggers the means of ultrasonic vibrations 5 to begin vibrating. Secondly, the draw reduces the pressure outside the reservoir chamber 21 such that flow of the liquid through the apertures 20b′ begins, which saturates the capillary element 7. The capillary element 7 transports the liquid to the means of ultrasonic vibrations 5, which causes bubbles to form in a capillary channel by the means of ultrasonic vibrations 5 and mist the liquid. Then, the mist liquid is drawn by the user.


The ultrasonic mist inhaler 100 of the present disclosures is a more powerful version of current portable medical nebulizers, in the shape and size of current e-cigarettes and with a particular structure for effective vaporization. It is a healthier alternative to cigarettes and current e-cigarettes products.


The ultrasonic mist inhaler 100 of the present disclosures has particular applicability for those who use electronic inhalers as a means to quit smoking and reduce their nicotine dependency. The ultrasonic mist inhaler 100 provides a way to gradually taper the dose of nicotine.



FIG. 5 illustrate a second arrangement of means of ultrasonic vibrations disposed close to or at a top surface of the liquid chamber.


The mouthpiece 1 is extending down to the bottom end of the inner container 20b. While the liquid chamber 21 is delimited by the outer container 20c and an inner peripheral container 20e joined by a bottom wall 25. The liquid chamber is closed by a top wall 23.


The top wall 23 has the top surface 23 representing the maximum level of the liquid that the liquid chamber 21 may contain and the bottom surface 25 representing the minimum level of the liquid in the liquid chamber 21. The top wall 23 is sealed, thus preventing leakage of liquid from the liquid chamber 21 to the mouthpiece 1.


As depicted in FIG. 5, the means of ultrasonic vibrations 5 has a flat shape having an atomization surface 50 parallel to the top surface 23 and disposed close to or at the top surface 23.


The top wall 23 is fixed to the liquid reservoir structure 2 by means of fixation such as screws or glue.


Contrary to the first arrangement, the capillary element 7 is not shown to make the illustrated features more clear.


Of course, the capillary element 7 may have the same configuration that the first arrangement. In this second arrangement, the L-shape is extending down to the bottom surface 25.



FIG. 6 illustrate a second arrangement of means of ultrasonic vibrations disposed close to or at a top surface of the liquid chamber.


In the second arrangement, the liquid reservoir structure 2 may comprise an inner container 200c and an outer container 200b wherein the inner container 200c is surrounded by the outer container 200b, the inner container 200c forms the liquid chamber 21.


The capillary element 7 is wrapped around the circular shape of the means of ultrasonic vibrations 5.


Further, the means of ultrasonic vibrations 5 is supported by an elastic member 8 formed from an annular plate-shaped rubber.


The elastic member 8 has an inner hole wherein a groove 80 is designed for maintaining the capillary element 7 and the means of ultrasonic vibrations 5.


The inner container 200c has a flat opening into which the elastic member 8 is introduced at least partly, the elastic member 8 having a radial groove 80 wherein the capillary element 7 passes and penetrates the liquid chamber.


The inner container 200c is sealed with the elastic member 8, for example, by glue or mastic disposed around the peripheral of the flat opening.


In this third arrangement, the means of electrical contacts rise through electrical contact holes 200b1 and 200b2 on either side of inner container 200c and connect with the rear of the means of ultrasonic vibrations 5.


Other embodiments of the invented ultrasonic mist inhaler 100 are easily envisioned, including medicinal delivery devices.


It is to be understood that the above description is intended to be illustrative, and not restrictive. For example, the above-described embodiments may be used in combination with each other. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from its scope.

Claims
  • 1. An ultrasonic mist inhaler, comprising: a liquid reservoir structure comprising a first container forming a liquid chamber adapted to receive liquid to be atomized, the first container comprises a top wall, a bottom wall, and a side wall positioned between the top wall and the bottom wall, the top wall comprises an interior surface, an exterior surface and an upward facing curved surface is formed between the exterior surface and the interior surface of the top wall, the upward facing curved surface forms an aperture to provide access to the liquid chamber, the liquid chamber is formed by the interior surface of the top wall, wherein the interior surface of the top wall is a top surface of the liquid chamber representing a maximum level of the liquid chamber, wherein the bottom wall comprises an interior surface that is a bottom surface of the liquid chamber representing a minimum level of the liquid chamber, and wherein the top surface being in a plane,a sonication chamber in fluid communication with the liquid chamber, the sonication chamber comprising a piezoelectric transducer,a capillary material extending between the sonication chamber and the liquid chamber, andan annular elastic support structure for supporting the piezoelectric transducer, the elastic support structure having a plate-shaped configuration and an annular wall surrounding at least a portion of the piezoelectric transducer, the elastic support structure having a passage extending radially through a portion of the annular wall, the passage is formed by a groove that penetrates a lower wall portion of the annular wall, the lower wall portion comprising a curved bottom surface having a curved portion configured to face the upward facing curved surface of the first container, and wherein the curved portion extends below the top surface of the liquid chamber and into the liquid chamber,wherein the piezoelectric transducer is disposed adjacent to the top surface of the liquid chamber,wherein the piezoelectric transducer has an atomization surface being in a plane perpendicular to the plane of the top surface of the liquid chamber, the aperture in the top wall of the first container is sized and configured to receive the lower wall portion and the groove therein, such that a portion of the groove and the curved portion are positioned within the liquid chamber and the curved portion is configured to engage the upward facing curved surface,wherein a portion of the capillary material passes through the groove of the elastic support structure and penetrates the liquid chamber.
  • 2. The ultrasonic mist inhaler according to claim 1, wherein the first container is an inner container, and the liquid reservoir structure further comprises an outer container and the inner container is surrounded by the outer container.
  • 3. The ultrasonic mist inhaler according to claim 1, wherein the capillary material is wrapped around the piezoelectric transducer.
  • 4. The ultrasonic mist inhaler according to claim 1, wherein the annular elastic support structure comprises an inner hole and a groove for retaining the piezoelectric transducer.
  • 5. The ultrasonic mist inhaler according to claim 1, wherein the annular elastic support structure is inserted into an opening by tight adjustment.
  • 6. The ultrasonic mist inhaler according to claim 1, wherein said liquid to be received in the liquid chamber comprises 57-70% (w/w) vegetable glycerin, 30-43% (w/w) propylene glycol, nicotine, and flavorings.
PCT Information
Filing Document Filing Date Country Kind
PCT/IB2019/060808 12/15/2019 WO
Publishing Document Publishing Date Country Kind
WO2021/123867 6/24/2021 WO A
US Referenced Citations (158)
Number Name Date Kind
4119096 Drews Oct 1978 A
4334531 Reichl Jun 1982 A
5355873 Del Bon Oct 1994 A
5518179 Humberstone et al. May 1996 A
5551416 Stimpson Sep 1996 A
5894841 Voges Apr 1999 A
6011345 Murray Jan 2000 A
6040560 Fleischhauer Mar 2000 A
6402046 Loser Jun 2002 B1
6601581 Babaev Aug 2003 B1
6679436 Onishi et al. Jan 2004 B1
7129619 Yang et al. Oct 2006 B2
8991722 Friend Mar 2015 B2
9242263 Copeman Jan 2016 B1
9278365 Banco et al. Mar 2016 B2
9415412 Kawashima Aug 2016 B2
9687029 Liu Jun 2017 B2
9687627 Gallem et al. Jun 2017 B2
9718078 Chau Aug 2017 B1
9867398 Guo et al. Jan 2018 B2
9980140 Spencer May 2018 B1
10034495 Alarcon Jul 2018 B2
10071391 Yu Sep 2018 B2
10195368 Wang et al. Feb 2019 B2
10327479 Popplewell Jun 2019 B2
10328218 Reed et al. Jun 2019 B2
10506827 Liu Dec 2019 B2
10561803 Liu et al. Feb 2020 B2
10617150 Cameron Apr 2020 B2
10757971 Liu Sep 2020 B2
11039641 Liu Jun 2021 B2
11207711 Hejazi Dec 2021 B2
11219245 Liu Jan 2022 B2
11278055 Liu Mar 2022 B2
11304451 Hejazi Apr 2022 B2
11431242 Liu Aug 2022 B2
11517685 Danek Dec 2022 B2
11589609 Liu Feb 2023 B2
11690963 Danek Jul 2023 B2
11700881 Liu Jul 2023 B2
11744282 Liu Sep 2023 B2
11744284 Liu Sep 2023 B2
11771137 Liu Oct 2023 B2
20020129813 Litherland Sep 2002 A1
20030192532 Hopkins Oct 2003 A1
20030209005 Fenn Nov 2003 A1
20040099218 Yang et al. May 2004 A1
20060243277 Denyer Nov 2006 A1
20070125370 Denyer Jun 2007 A1
20080088202 Duru Apr 2008 A1
20080156320 Low Jul 2008 A1
20080164339 Duru Jul 2008 A1
20090022669 Waters Jan 2009 A1
20100084488 Mahoney, III Apr 2010 A1
20100139652 Lipp Jun 2010 A1
20120126041 Mahito et al. May 2012 A1
20130220315 Conley Aug 2013 A1
20140007864 Gordon et al. Jan 2014 A1
20140151457 Wilkerson Jun 2014 A1
20140261414 Weitzel Sep 2014 A1
20140270727 Ampolini Sep 2014 A1
20150202387 Yu Jul 2015 A1
20150230522 Horn et al. Aug 2015 A1
20150231347 Gumaste et al. Aug 2015 A1
20150273500 Banco et al. Oct 2015 A1
20160001316 Friend Jan 2016 A1
20160015081 Liu Jan 2016 A1
20160066619 Di Carlo Mar 2016 A1
20160089508 Smith Mar 2016 A1
20160199594 Finger Jul 2016 A1
20160206001 Eng Jul 2016 A1
20160213866 Tan Jul 2016 A1
20160264290 Hafer Sep 2016 A1
20160279352 Wang et al. Sep 2016 A1
20160295913 Guo et al. Oct 2016 A1
20160324212 Cameron Nov 2016 A1
20170042242 Hon Feb 2017 A1
20170106155 Reed et al. Apr 2017 A1
20170119052 Williams May 2017 A1
20170135411 Cameron May 2017 A1
20170136484 Wilkerson May 2017 A1
20170265521 Do Sep 2017 A1
20170281883 Li Oct 2017 A1
20170303594 Cameron Oct 2017 A1
20170368273 Rubin Dec 2017 A1
20180042306 Atkins Feb 2018 A1
20180153217 Liu Jun 2018 A1
20180160737 Verleur Jun 2018 A1
20180161525 Liu Jun 2018 A1
20180192702 Li Jul 2018 A1
20180269867 Terashima Sep 2018 A1
20180286207 Baker Oct 2018 A1
20180296777 Terry Oct 2018 A1
20180296778 Hacker Oct 2018 A1
20180310625 Alarcon Nov 2018 A1
20180338532 Verleur Nov 2018 A1
20180343926 Wensley Dec 2018 A1
20190056131 Warren Feb 2019 A1
20190098935 Phan Apr 2019 A1
20190116863 Dull Apr 2019 A1
20190158938 Bowen May 2019 A1
20190166913 Trzecieski Jun 2019 A1
20190216135 Guo Jul 2019 A1
20190255554 Selby Aug 2019 A1
20190289914 Liu Sep 2019 A1
20190289915 Heidl Sep 2019 A1
20190289918 Hon Sep 2019 A1
20190321570 Rubin Oct 2019 A1
20190329281 Lin Oct 2019 A1
20190335580 Lin Oct 2019 A1
20190336710 Yamada Nov 2019 A1
20190373679 Fu Dec 2019 A1
20190374730 Chen Dec 2019 A1
20190387795 Fisher Dec 2019 A1
20200000143 Anderson Jan 2020 A1
20200000146 Anderson Jan 2020 A1
20200009600 Tan Jan 2020 A1
20200016344 Scheck et al. Jan 2020 A1
20200022416 Alarcon Jan 2020 A1
20200046030 Krietzman Feb 2020 A1
20200068949 Rasmussen Mar 2020 A1
20200085100 Hoffman Mar 2020 A1
20200120989 Danek Apr 2020 A1
20200120991 Hatton Apr 2020 A1
20200146361 Silver May 2020 A1
20200178598 Mitchell Jun 2020 A1
20200214349 Liu Jul 2020 A1
20200221771 Atkins Jul 2020 A1
20200221776 Liu Jul 2020 A1
20200245692 Cameron Aug 2020 A1
20200345058 Bowen Nov 2020 A1
20200404975 Chen Dec 2020 A1
20210015957 Bush Jan 2021 A1
20210076733 Liu Mar 2021 A1
20210112858 Liu Apr 2021 A1
20210153548 Twite May 2021 A1
20210153549 Twite May 2021 A1
20210153564 Hourmand May 2021 A1
20210153565 Twite May 2021 A1
20210153566 Hourmand May 2021 A1
20210153567 Twite May 2021 A1
20210153568 Twite May 2021 A1
20210153569 Twite May 2021 A1
20210177056 Yilmaz Jun 2021 A1
20210212362 Liu Jul 2021 A1
20210378303 Liu Dec 2021 A1
20210401061 Davis Dec 2021 A1
20220030942 Lord Feb 2022 A1
20220151301 Liu May 2022 A1
20220240589 Liu Aug 2022 A1
20220273037 Liu Sep 2022 A1
20220279857 Liu Sep 2022 A1
20220295876 Liu Sep 2022 A1
20220395023 Liu Dec 2022 A1
20220400747 Liu Dec 2022 A1
20230001107 Connolly Jan 2023 A1
20230013741 Liu Jan 2023 A1
20230020762 Liu Jan 2023 A1
Foreign Referenced Citations (175)
Number Date Country
101648041 Feb 2010 CN
104055225 Sep 2014 CN
204070580 Jan 2015 CN
204499481 Jul 2015 CN
105747277 Jul 2016 CN
105768238 Jul 2016 CN
105795526 Jul 2016 CN
105876873 Aug 2016 CN
205432145 Aug 2016 CN
106108118 Nov 2016 CN
205831074 Dec 2016 CN
106422005 Feb 2017 CN
205947130 Feb 2017 CN
206025223 Mar 2017 CN
206043451 Mar 2017 CN
206079025 Apr 2017 CN
206119183 Apr 2017 CN
206119184 Apr 2017 CN
106617319 May 2017 CN
206303211 Jul 2017 CN
206333372 Jul 2017 CN
107048479 Aug 2017 CN
206586397 Oct 2017 CN
206949536 Feb 2018 CN
207185926 Apr 2018 CN
105476071 May 2018 CN
207400330 May 2018 CN
108283331 Jul 2018 CN
108355210 Aug 2018 CN
105876873 Dec 2018 CN
109619655 Jan 2019 CN
208354603 Jan 2019 CN
208434721 Jan 2019 CN
106108118 Apr 2019 CN
106108118 Apr 2019 CN
208837110 May 2019 CN
209060228 Jul 2019 CN
110150760 Aug 2019 CN
209255084 Aug 2019 CN
105876870 Nov 2019 CN
209900345 Jan 2020 CN
210076566 Feb 2020 CN
210225387 Mar 2020 CN
110946315 Apr 2020 CN
2656370 Jun 1978 DE
2656370 Nov 1978 DE
2656370 Jul 1979 DE
100 51 792 May 2002 DE
10122065 Dec 2002 DE
0 258 637 Mar 1988 EP
0 295 122 Dec 1988 EP
0 258 637 Jun 1990 EP
0 442 510 Aug 1991 EP
0 442 510 Jan 1995 EP
0 516 565 Apr 1996 EP
0 824 927 Feb 1998 EP
0 833 695 Apr 1998 EP
0 845 220 Jun 1998 EP
0 893 071 Jan 1999 EP
0 970 627 Jan 2000 EP
1 083 952 Mar 2001 EP
1 618 803 Dec 2008 EP
3 088 007 Nov 2016 EP
3 088 007 Nov 2016 EP
3 192 381 Jul 2017 EP
3 278 678 Feb 2018 EP
3 298 912 Mar 2018 EP
3 088 007 Nov 2018 EP
3 278 678 Nov 2018 EP
3 434 118 Jan 2019 EP
3 469 927 Apr 2019 EP
3 505 098 Jul 2019 EP
3 520 634 Aug 2019 EP
3 278 678 Oct 2019 EP
3 434 118 Oct 2019 EP
3 545 778 Oct 2019 EP
3 574 902 Dec 2019 EP
3 516 971 Mar 2021 EP
3 528 651 May 2021 EP
3 837 999 Jun 2021 EP
3 574 778 Jul 2021 EP
3 593 656 Oct 2021 EP
4 033 927 Nov 2023 EP
3043576 May 2017 FR
3064502 Oct 2018 FR
1 528 391 Oct 1978 GB
2566766 Mar 2019 GB
2570439 Jul 2019 GB
05093575 Dec 1993 JP
2579614 Aug 1998 JP
2001069963 Mar 2001 JP
2005288400 Oct 2005 JP
2008-104966 May 2008 JP
2008104966 May 2008 JP
2011-500160 Jan 2011 JP
2012-507208 Mar 2012 JP
2014-004042 Jan 2014 JP
2019-515690 Jun 2019 JP
2019-521671 Aug 2019 JP
2019521671 Aug 2019 JP
2019-524113 Sep 2019 JP
2019-526240 Sep 2019 JP
2019-526241 Sep 2019 JP
2020535846 Dec 2020 JP
20120107219 Oct 2012 KR
10-2013-0052119 May 2013 KR
10-2013-0095024 Aug 2013 KR
WO 9221332 Dec 1992 WO
WO 9309881 May 1993 WO
WO-9964095 Dec 1999 WO
WO-9964095 Dec 1999 WO
WO 2000050111 Aug 2000 WO
WO 2002055131 Jul 2002 WO
WO 02094342 Nov 2002 WO
WO 2003055486 Jul 2003 WO
WO 20030101454 Dec 2003 WO
WO 2007083088 Jul 2007 WO
WO 2008076717 Jun 2008 WO
WO 2009096346 Aug 2009 WO
WO 2012062600 May 2012 WO
WO 2012138835 Oct 2012 WO
WO-2013028934 Feb 2013 WO
WO 2014182736 Nov 2014 WO
WO 2015128499 Mar 2015 WO
WO2015084544 Jun 2015 WO
WO 2015115006 Aug 2015 WO
WO 2016010864 Jan 2016 WO
WO 20160116386 Jul 2016 WO
WO-2016118941 Jul 2016 WO
WO-2016175720 Nov 2016 WO
WO-2016196915 Dec 2016 WO
WO-2017076590 May 2017 WO
WO 2017108268 Jun 2017 WO
WO-2017108268 Jun 2017 WO
WO 2017143515 Aug 2017 WO
WO 2017177159 Oct 2017 WO
WO 2017197704 Nov 2017 WO
WO 2017206022 Dec 2017 WO
WO 2017206212 Dec 2017 WO
WO 2017215221 Dec 2017 WO
WO 2018000761 Jan 2018 WO
WO 2018000829 Jan 2018 WO
WO 2018023920 Feb 2018 WO
WO-2018027189 Feb 2018 WO
WO 2018032672 Feb 2018 WO
WO 2018040380 Mar 2018 WO
WO-2018041106 Mar 2018 WO
WO 2018058884 Apr 2018 WO
WO 2018111843 Jun 2018 WO
WO-2018113669 Jun 2018 WO
WO 2018115781 Jun 2018 WO
WO-2018163366 Sep 2018 WO
WO 2018167066 Sep 2018 WO
WO 2018188616 Oct 2018 WO
WO 2018188638 Oct 2018 WO
WO-2018211252 Nov 2018 WO
WO-2018220586 Dec 2018 WO
WO-2018220599 Dec 2018 WO
WO 2019048749 Mar 2019 WO
WO-2019052506 Mar 2019 WO
WO-2019052574 Mar 2019 WO
WO 2019069160 Apr 2019 WO
WO-2019138076 Jul 2019 WO
WO 2019198688 Oct 2019 WO
WO-2019198688 Oct 2019 WO
WO 2019211324 Nov 2019 WO
WO 2019238064 Dec 2019 WO
WO 2019242746 Dec 2019 WO
WO 2020019030 Jan 2020 WO
WO-2020057636 Mar 2020 WO
WO2020187138 Sep 2020 WO
WO-2020225534 Nov 2020 WO
WO 2020225534 Nov 2020 WO
WO 2020254862 Dec 2020 WO
WO-2021036827 Mar 2021 WO
Non-Patent Literature Citations (20)
Entry
English translation for JP 2008104966, machine translated by Search Clarivate Analytics, translated on Oct. 17, 2023.
International Search Report dated Jun. 25, 2020, from application No. PCT/IB2019/060808.
Combined Search and Examination Report dated Nov. 24, 2021, from application No. 2111261.0, 9 pages.
Combined Search and Examination Report dated Nov. 24, 2021, from application No. 2113623.9, 9 pages.
European Extended Search Report dated Jun. 22, 2021, from application No. 19870057.7, 9 pages.
Extended European Search Report dated May 26, 2021, from application No. 20214228.7, 18 pages.
Extended European Search Report dated Nov. 12, 2021, from application No. 19870060.1, 8 pages.
Extended European Search Report dated Nov. 9, 2020, from application No. 19870059.3, 7 pages.
Extended European Search Report dated Oct. 27, 2021, from application No. 19870058.5, 8 pages.
Extended European Search Report dated Sep. 15, 2020, from application No. 20168938.7, 8 pages.
International Search Report and Written Opinion dated Apr. 29, 2020, from application No. PCT/IB2019/055192, 7 pages.
International Search Report and Written Opinion dated Nov. 10, 2020, from application No. PCT/IB2019/060812, 9 pages.
International Search Report and Written Opinion dated Nov. 4, 2020, from application No. PCT/IB2019/060807, 9 pages.
International Search Report and Written Opinion dated Oct. 19, 2020, from application No. PCT/IB2019/060810, 8 pages.
International Search Report and Written Opinion dated Oct. 20, 2020, from application No. PCT/IB2019/060811, 9 pages.
International Search Report and Written Opinion Nov. 4, 2020, from application No. PCT/IB2019/060806, 8 pages.
Extended European Search Report issued by the European Patent Office for the corresponding EP Application No. 22181106.0, dated Nov. 15, 2022, 10 pages.
Extended Search Report issued by the European Patent Office, dated Dec. 1, 2022, 11 pages, for corresponding European Patent Application No. 1993337.8.
Reasons for Rejection with English translation, issued by the Japanese Patent Office dated Nov. 1, 2022, 5 pages, for corresponding Japanese Patent Application No. 2022-545772.
Office Action, co-pending KR Application No. 10-2022-7024269 dated Dec. 20, 2023; 6 pages.
Related Publications (1)
Number Date Country
20220001121 A1 Jan 2022 US